Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

NCT06484868 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Lipodystrophy

Interventions

DRUG: Metreleptin

Sponsor

Amryt Pharma